ID: 129935219 | ATAC-STARR-seq lymphoblastoid active region 16835 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (182553648..182553857) | | |
ID: 129935218 | ATAC-STARR-seq lymphoblastoid silent region 12160 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (181892227..181892366) | | |
ID: 129935217 | ATAC-STARR-seq lymphoblastoid silent region 12159 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (181891607..181891936) | | |
ID: 129660871 | ReSE screen-validated silencer GRCh37_chr2:183364154-183364284 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (182499427..182499557) | | |
ID: 129388964 | MPRA-validated peak3964 silencer [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (181944208..181944408) | | |
ID: 129388963 | MPRA-validated peak3963 silencer [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (181932368..181932568) | | |
ID: 129388962 | MPRA-validated peak3962 silencer [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (181932128..181932328) | | |
ID: 129388961 | MPRA-validated peak3961 silencer [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (181848448..181848648) | | |
ID: 127275364 | OCT4-NANOG hESC enhancer GRCh37_chr2:183490526-183491063 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (182625799..182626336) | | |
ID: 127275363 | NANOG hESC enhancer GRCh37_chr2:183456476-183457108 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (182591749..182592381) | | |
ID: 127275362 | NANOG hESC enhancer GRCh37_chr2:183364377-183364935 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (182499650..182500208) | | |
ID: 127275361 | NANOG hESC enhancer GRCh37_chr2:182975215-182975716 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (182110488..182110989) | | |
ID: 126806442 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr2:183516578-183517777 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (182651851..182653050) | | |
ID: 126806441 | MED14-independent group 3 enhancer GRCh37_chr2:182819339-182820538 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (181954612..181955811) | | |
ID: 126806440 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr2:182655450-182656649 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (181790723..181791922) | | |
ID: 124907915 | uncharacterized LOC124907915 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (182332057..182342463, complement) | | |
ID: 122861262 | Sharpr-MPRA regulatory region 15031 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (181886302..181886596) | | |
ID: 122861261 | Sharpr-MPRA regulatory region 14896 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (181776382..181776676) | | |
ID: 112806063 | Sharpr-MPRA regulatory region 14191 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (181810862..181811156) | | |
ID: 108281145 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr2:182740630-182741829 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (181875903..181877122) | | |